Search

Displaying results 3371 - 3380 of 5302 in total
  1. Drug

    Gusacitinib

    go.drugbank.com/drugs/DB15670
    Investigational

    Gusacitinib is under investigation in clinical trial NCT02550678 (A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma).

  2. Drug

    D-Treitol

    go.drugbank.com/drugs/DB03278
    Experimental

    It is twice as sweet as sucrose and can be used as a coronary vasodilator. [PubChem]

  3. Drug

    Droloxifene

    go.drugbank.com/drugs/DB15641
    Experimental

    Droloxifene may have an effect on bone and breast tissue because it induces apoptosis. … It may have a particular role in situations in which rapid pharmacokinetics, or an increased antiestrogenic to estrogenic ratio, are required.

  4. Drug

    Trimegestone

    go.drugbank.com/drugs/DB13129
    Investigational

    Trimegestone has been used in trials studying the treatment of Postmenopause.

    Categories: Genito Urinary System and Sex Hormones, Sex Hormones and Modulators of the Genital System
  5. Drug

    Epimestrol

    go.drugbank.com/drugs/DB13386
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Sex Hormones and Modulators of the Genital System
  6. Drug

    LGD-3303

    go.drugbank.com/drugs/DB13937
    Experimental

    An androgen receptor modulator.

  7. Drug

    Beclomethasone 17-monopropionate

    go.drugbank.com/drugs/DB14221
    Experimental

    An ester of beclomethasone.

  8. Drug

    LGD-2226

    go.drugbank.com/drugs/DB08089
    Experimental

    An androgen receptor modulator.

  9. Drug

    Felzartamab

    go.drugbank.com/drugs/DB16375
    Investigational

    Felzartamab is under investigation in clinical trial NCT04145440 (Trial to Assess Safety and Efficacy of MOR202 in Anti-pla2r + Membranous Nephropathy (Amn)).

  10. Drug

    Lonafarnib

    go.drugbank.com/drugs/DB06448
    ApprovedInvestigational

    [A224379, A224384, A224389, A224394, A224399] Mechanistically, HGPS is underpinned by a single heterozygous C-to-T mutation at position 1824 of the _LMNA_ gene, which results in the accumulation of an